Literature DB >> 20440581

Identification of tumor-associated antigens from medullary breast carcinoma by a modified SEREX approach.

Ramziya Kiyamova1, Olga Kostianets, Sergey Malyuchik, Valeriy Filonenko, Vasiliy Usenko, Vadym Gurtovyy, Yuliya Khozayenko, Stepan Antonuk, Lloyd Old, Ivan Gout.   

Abstract

Medullary breast carcinoma (MBC) is a relatively rare malignancy with heavy lymphocytic infiltration that despite cytologically anaplastic features and high mitotic index has more favorable prognosis than other types of breast cancer. Lymphocytic infiltration of tumors reflects ongoing immune response against tumor antigens which could represent a great interest as potential targets for cancer immunotherapy. The search for MBC antigens by SEREX methodology has not been successful due to a very high titer of false positive clones, representing immunoglobulin genes. Here, we describe a novel approach for generating cDNA expression libraries from MBC tumor samples which are depleted of IgG cDNA clones and, therefore, are suitable for the identification of novel tumor-associated antigens (TAA) by SEREX approach. Modified methodology allowed us to isolate a panel of known and novel TAA which are currently under further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440581     DOI: 10.1007/s12033-010-9285-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  14 in total

1.  Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes.

Authors:  Beatrix Kotlan; Peter Simsa; Jean-Luc Teillaud; Wolf Herman Fridman; Jozsef Toth; Michael McKnight; Mark C Glassy
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

Review 2.  Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.

Authors:  T Boon
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

3.  Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-ichi Tamaru; Goi Sakamoto; Kiyoshi Ohnisi; Shinji Itoyama
Journal:  Virchows Arch       Date:  2004-11-30       Impact factor: 4.064

4.  Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen.

Authors:  R F Wang; X Wang; A C Atwood; S L Topalian; S A Rosenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 5.  High throughput proteomic strategies for identifying tumour-associated antigens.

Authors:  C Geeth Gunawardana; Eleftherios P Diamandis
Journal:  Cancer Lett       Date:  2007-02-15       Impact factor: 8.679

6.  The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells.

Authors:  M H Hansen; H Nielsen; H J Ditzel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

7.  Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.

Authors:  M J Mattes; K Look; K Furukawa; V K Pierce; L J Old; J L Lewis; K O Lloyd
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

Review 8.  Serological identification of human tumor antigens.

Authors:  U Sahin; O Türeci; M Pfreundschuh
Journal:  Curr Opin Immunol       Date:  1997-10       Impact factor: 7.486

9.  Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2).

Authors:  M R Parkhurst; E B Fitzgerald; S Southwood; A Sette; S A Rosenberg; Y Kawakami
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

10.  Cancer vaccines: an overview.

Authors:  Lloyd J Old
Journal:  Cancer Immun       Date:  2008-03-12
View more
  4 in total

1.  Construction of random tumor transcriptome expression library for creating and selecting novel tumor antigens.

Authors:  Huizhun Zhao; Xiuyun Zhao; Peng Du; Gaofu Qi
Journal:  Tumour Biol       Date:  2016-07-23

2.  Applying bioinformatics for antibody epitope prediction using affinity-selected mimotopes - relevance for vaccine design.

Authors:  Galina F Denisova; Dimitri A Denisov; Jonathan L Bramson
Journal:  Immunome Res       Date:  2010-11-03

3.  Autoantibody Response to ZRF1 and KRR1 SEREX Antigens in Patients with Breast Tumors of Different Histological Types and Grades.

Authors:  Lada Dyachenko; Kristina Havrysh; Anita Lytovchenko; Irina Dosenko; Stepan Antoniuk; Valeriy Filonenko; Ramziya Kiyamova
Journal:  Dis Markers       Date:  2016-10-25       Impact factor: 3.434

4.  Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.

Authors:  Olga Kostianets; Stepan Antoniuk; Valeriy Filonenko; Ramziya Kiyamova
Journal:  Diagn Pathol       Date:  2012-11-26       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.